BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | Company Announcement
Investegate announcements from BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) ...
MALVERN, Pa., May 03, 2024 -- Galera Therapeutics, Inc. , a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to transform...
LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...
/PRNewswire/ -- Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger...